APA (7th ed.) Citation

Scheffges, C., Devy, J., Giustiniani, J., Francois, S., Cartier, L., Merrouche, Y., . . . Marie-Cardine, A. (2024). Identification of CD160-TM as a tumor target on triple negative breast cancers: Possible therapeutic applications. Breast cancer research : BCR, 26(1), 28-13. https://doi.org/10.1186/s13058-024-01785-x

Chicago Style (17th ed.) Citation

Scheffges, Claire, et al. "Identification of CD160-TM as a Tumor Target on Triple Negative Breast Cancers: Possible Therapeutic Applications." Breast Cancer Research : BCR 26, no. 1 (2024): 28-13. https://doi.org/10.1186/s13058-024-01785-x.

MLA (9th ed.) Citation

Scheffges, Claire, et al. "Identification of CD160-TM as a Tumor Target on Triple Negative Breast Cancers: Possible Therapeutic Applications." Breast Cancer Research : BCR, vol. 26, no. 1, 2024, pp. 28-13, https://doi.org/10.1186/s13058-024-01785-x.